Icon Genetics GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Icon Genetics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013244
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icon Genetics GmbH (Icon Genetics) a subsidiary of Bayer AG is a biotechnology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plant-based production. It also develops and commercializes proprietary transgene operating systems suites of technologies for nuclear transformation of plants, plastid transformation and pro-viral transfection of plants. Icon Genetics discovers and develops biopharmaceuticals and protein products using green plants as production hosts. The company provides its production platforms and product prototypes for pharmaceutical, animal health and chemical biotech markets. Icon Genetics is headquartered in Halle, Germany.

Icon Genetics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Merger 11
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Acquisition 12
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH – Key Competitors 14
Icon Genetics GmbH – Key Employees 15
Icon Genetics GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Icon Genetics GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH, Key Competitors 14
Icon Genetics GmbH, Key Employees 15

★海外企業調査レポート[Icon Genetics GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sensus USA Inc.-エネルギー分野:企業M&A・提携分析
    Summary Sensus USA Inc. (Sensus), a Xylem brand, is a clean technology solutions company that designs and manufactures smart meters, communication systems, and software. It provides smart meters, network technologies, and advanced data analytics solutions. Sensus’s solutions collects data related to …
  • Emirates NBD Bank:企業の戦略・SWOT・財務分析
    Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CooperVision Inc:企業の製品パイプライン分析2018
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Synedgen Inc-医療機器分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Trafigura Group Pte Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Trafigura Group Pte Ltd (Trafigura), a subsidiary of Trafigura Beheer B.V., is an independent commodity trading and logistics company. Its operations include trading of physical commodities, shipping and chartering, and asset management. The company sources, stores, blends, and delivers a ra …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • Kerecis ehf:製薬・医療:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • Knott’s Berry Farm:企業の戦略的SWOT分析
    Knott's Berry Farm - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Nisshin OilliO Group, Ltd.:企業の戦略・SWOT・財務情報
    The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Akashi Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Akashi Therapeutics Inc (Akashi Therapeutics), formerly DART Therapeutics Inc is a clinical stage biopharmaceutical company develops treatment for duchenne muscular dystrophy (DMD) and other rare pediatric diseases. The company provides pipeline portfolio such as HT-100, a small molecule dru …
  • Vail Resorts Inc:戦略・SWOT・企業財務分析
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Reliance Infrastructure Ltd.:企業の戦略・SWOT・財務情報
    Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Laboratorios LETI SL:企業の戦略的SWOT分析
    Laboratorios LETI SL - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tel-Instrument Electronics Corp.:企業の戦略・SWOT・財務情報
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lincoln Pharmaceuticals Ltd (Lincoln Pharmaceuticals) manufactures, markets and exports pharmaceutical products. The company provides pharmaceuticals for cardiovascular, central nervous system, dermatology and ear nose throat disorders; gastrointestinal and genitourinary infections; hematolo …
  • hopTo Inc. (HPTO):企業の財務・戦略的SWOT分析
    hopTo Inc. (HPTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆